Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 1.93 | 1.85 |
NAV | ₹29.09 | ₹19.00 |
Fund Started | 22 Jan 2015 | 24 Jan 2022 |
Fund Size | ₹3179.19 Cr | ₹4390.12 Cr |
Exit Load | - | Exit load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -0.20% | 2.59% |
3 Year | 16.71% | 21.37% |
5 Year | 19.68% | - |
1 Year
3 Year
5 Year
Equity | 99.50% | 96.17% |
Cash | 0.50% | 3.83% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
HDFC Bank Ltd. | 6.97% |
ICICI Bank Ltd. | 6.78% |
Reliance Industries Ltd. | 4.40% |
State Bank of India | 3.70% |
Larsen & Toubro Ltd. | 3.45% |
Infosys Ltd. | 3.40% |
Bajaj Finance Ltd. | 3.30% |
NTPC Ltd. | 2.68% |
Bharti Airtel Ltd. | 2.65% |
Mahindra & Mahindra Ltd. | 2.52% |
Name | Assets |
|---|---|
ICICI Bank Ltd. | 5.78% |
HDFC Bank Ltd. | 4.10% |
Eternal Ltd. | 4.10% |
Interglobe Aviation Ltd. | 4.00% |
Trent Ltd. | 3.47% |
Larsen & Toubro Ltd. | 2.99% |
Cholamandalam Investment and Finance Company Ltd. | 2.93% |
TVS Motor Company Ltd. | 2.69% |
Max Healthcare Institute Ltd. | 2.59% |
Sai Life Sciences Ltd. | 2.53% |
Name | Akshay Sharma | Amit Ganatra |
Start Date | 01 Dec 2022 | 03 Oct 2025 |
Name
Start Date
Description | The scheme seeks to provide capital appreciation and consistent income to the investors which will be in line with their retirement goals by investing in a mix of securities comprising of equity, equity related instruments and fixed income securities. | The scheme seeks to generate capital appreciation by dynamically investing in a mix of equity and equity related instruments across market capitalization i.e. large, mid and small cap stocks. |
Launch Date | 22 Jan 2015 | 24 Jan 2022 |
Description
Launch Date